ISRN Obstetrics and Gynecology · 2013 · 30 citations · 18 references
MedicinePharmacologyPharmacotherapyGeneral GynecologyReproductive MedicineWomen's Health PharmacotherapyUterine Fibroid PharmacotherapyUterine FibroidsUterine LeiomyomaFibroid Size AssessmentFibroid Volume ReductionPharmacologic Therapy For FibroidsRandomized Clinical TrialsRandomized Controlled Trial BaselineSymptomatic Disease PrevalenceSymptomatic PrevalenceUterine Fibroid Evaluation
Objectives. To evaluate the efficacy, safety, and quality of life by using 2.5 and mifepristone 5 mg daily doses to treat uterine fibroids over 3 months with a 9-month followup period. Design. Randomized clinical trial. Place. "Eusebio Hernández" Hospital, Havana, Cuba. Subjects. 220 women with symptomatic uterine fibroids. Treatment. One-half (2.5 mg) or one-whole 5 mg mifepristone tablet. Variables to Evaluate Efficacy. Changes in fibroid and uterine volumes, in symptomatic prevalence and intensity, and in quality of life. Results. After 3-month treatment, fibroid volume decreased by 27.9% (CI 95% 20-35) and 45.5% (CI 95% 37-62), in the 2.5 and 5 mg groups, respectively, P = 0.003. There was no difference in the prevalence of symptoms at the end of treatment, unlike after 6- and 9-month followup when there was a difference. Amenorrhea was significantly higher in the 5 mg group, P = 0.001. There were no significant differences in mifepristone side effects between the groups. Both groups displayed a similar improvement in quality of life. Conclusions. The 2.5 mg dosage resulted in a lesser reduction in fibroid size but a similar improvement in quality of life when compared to the 5 mg dose. This trial is registered with ClinicalTrials.gov NCT01786226.
18
The spectrum of endometrial pathology induced by progesterone receptor modulators
George L. Mutter, Christine Bergeron, Liane Deligdisch et al. · Modern Pathology · 2008 · 233 citations · Full text
Medicine, Endocrinology, Gynecology +14
Low-dose mifepristone for uterine leiomyomata
Steven H. Eisinger · Obstetrics and Gynecology · 2003 · 164 citations
CDB-2914 for Uterine Leiomyomata Treatment
Eric D. Levens, Clariss Potlog‐Nahari, Alicia Armstrong et al. · Obstetrics and Gynecology · 2008 · 155 citations · Full text
Medicine, Endocrinology, Gynecology +17